nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinblastine—JUN—Irbesartan—type 2 diabetes mellitus	0.244	0.54	CbGbCtD
Vinblastine—ABCC2—type 2 diabetes mellitus	0.178	0.694	CbGaD
Vinblastine—CYP3A4—type 2 diabetes mellitus	0.0785	0.307	CbGaD
Vinblastine—ABCB11—Glyburide—type 2 diabetes mellitus	0.0273	0.0603	CbGbCtD
Vinblastine—ABCC1—Glyburide—type 2 diabetes mellitus	0.0194	0.0429	CbGbCtD
Vinblastine—ABCC2—Glyburide—type 2 diabetes mellitus	0.0143	0.0317	CbGbCtD
Vinblastine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0142	0.0314	CbGbCtD
Vinblastine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0126	0.0279	CbGbCtD
Vinblastine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0106	0.0235	CbGbCtD
Vinblastine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00913	0.0202	CbGbCtD
Vinblastine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0086	0.019	CbGbCtD
Vinblastine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00849	0.0188	CbGbCtD
Vinblastine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00794	0.0176	CbGbCtD
Vinblastine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00757	0.0167	CbGbCtD
Vinblastine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00692	0.0153	CbGbCtD
Vinblastine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00652	0.0144	CbGbCtD
Vinblastine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00627	0.0139	CbGbCtD
Vinblastine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00625	0.0138	CbGbCtD
Vinblastine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00605	0.0134	CbGbCtD
Vinblastine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00547	0.0121	CbGbCtD
Vinblastine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00467	0.0103	CbGbCtD
Vinblastine—ABCB1—Losartan—type 2 diabetes mellitus	0.00427	0.00946	CbGbCtD
Vinblastine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00415	0.00917	CbGbCtD
Vinblastine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00397	0.0088	CbGbCtD
Vinblastine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00397	0.0088	CbGbCtD
Vinblastine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00376	0.00832	CbGbCtD
Vinblastine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0028	0.0062	CbGbCtD
Vinblastine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00256	0.00567	CbGbCtD
Vinblastine—TUBA1A—peripheral nervous system—type 2 diabetes mellitus	0.0021	0.033	CbGeAlD
Vinblastine—JUN—peripheral nervous system—type 2 diabetes mellitus	0.00208	0.0327	CbGeAlD
Vinblastine—TUBA1A—nerve—type 2 diabetes mellitus	0.00164	0.0257	CbGeAlD
Vinblastine—JUN—artery—type 2 diabetes mellitus	0.00164	0.0257	CbGeAlD
Vinblastine—JUN—nerve—type 2 diabetes mellitus	0.00162	0.0255	CbGeAlD
Vinblastine—TUBE1—islet of Langerhans—type 2 diabetes mellitus	0.00153	0.024	CbGeAlD
Vinblastine—JUN—endothelium—type 2 diabetes mellitus	0.00138	0.0217	CbGeAlD
Vinblastine—TUBG1—islet of Langerhans—type 2 diabetes mellitus	0.00137	0.0215	CbGeAlD
Vinblastine—TUBG1—retina—type 2 diabetes mellitus	0.00117	0.0184	CbGeAlD
Vinblastine—TUBD1—cortex of kidney—type 2 diabetes mellitus	0.00113	0.0177	CbGeAlD
Vinblastine—TUBG1—nephron tubule—type 2 diabetes mellitus	0.0011	0.0173	CbGeAlD
Vinblastine—TUBE1—pancreas—type 2 diabetes mellitus	0.00108	0.0169	CbGeAlD
Vinblastine—TUBE1—cortex of kidney—type 2 diabetes mellitus	0.00106	0.0166	CbGeAlD
Vinblastine—TUBD1—adipose tissue—type 2 diabetes mellitus	0.00104	0.0163	CbGeAlD
Vinblastine—TUBB6—Irbesartan—Valsartan—type 2 diabetes mellitus	0.00101	0.54	CbGdCrCtD
Vinblastine—TUBE1—adipose tissue—type 2 diabetes mellitus	0.000977	0.0153	CbGeAlD
Vinblastine—TUBG1—kidney—type 2 diabetes mellitus	0.00097	0.0152	CbGeAlD
Vinblastine—TUBG1—cortex of kidney—type 2 diabetes mellitus	0.000945	0.0148	CbGeAlD
Vinblastine—NR5A1—pancreas—type 2 diabetes mellitus	0.00094	0.0147	CbGeAlD
Vinblastine—TUBG1—adipose tissue—type 2 diabetes mellitus	0.000874	0.0137	CbGeAlD
Vinblastine—TUBB6—Irbesartan—Losartan—type 2 diabetes mellitus	0.000856	0.46	CbGdCrCtD
Vinblastine—ABCC6—retina—type 2 diabetes mellitus	0.000802	0.0126	CbGeAlD
Vinblastine—TUBA1A—islet of Langerhans—type 2 diabetes mellitus	0.000794	0.0125	CbGeAlD
Vinblastine—JUN—islet of Langerhans—type 2 diabetes mellitus	0.000786	0.0123	CbGeAlD
Vinblastine—TUBD1—liver—type 2 diabetes mellitus	0.000731	0.0115	CbGeAlD
Vinblastine—TUBB1—adipose tissue—type 2 diabetes mellitus	0.000695	0.0109	CbGeAlD
Vinblastine—TUBE1—liver—type 2 diabetes mellitus	0.000685	0.0107	CbGeAlD
Vinblastine—TUBA1A—retina—type 2 diabetes mellitus	0.000679	0.0106	CbGeAlD
Vinblastine—ABCC6—cardiovascular system—type 2 diabetes mellitus	0.000678	0.0106	CbGeAlD
Vinblastine—JUN—retina—type 2 diabetes mellitus	0.000672	0.0105	CbGeAlD
Vinblastine—ABCC6—kidney—type 2 diabetes mellitus	0.000664	0.0104	CbGeAlD
Vinblastine—TUBB2B—islet of Langerhans—type 2 diabetes mellitus	0.000656	0.0103	CbGeAlD
Vinblastine—TUBA1A—nephron tubule—type 2 diabetes mellitus	0.000639	0.01	CbGeAlD
Vinblastine—JUN—nephron tubule—type 2 diabetes mellitus	0.000633	0.00993	CbGeAlD
Vinblastine—TUBB—islet of Langerhans—type 2 diabetes mellitus	0.00062	0.00973	CbGeAlD
Vinblastine—TUBB2A—islet of Langerhans—type 2 diabetes mellitus	0.000617	0.00968	CbGeAlD
Vinblastine—TUBG1—liver—type 2 diabetes mellitus	0.000613	0.00962	CbGeAlD
Vinblastine—TUBB6—islet of Langerhans—type 2 diabetes mellitus	0.000609	0.00955	CbGeAlD
Vinblastine—ABCC6—adipose tissue—type 2 diabetes mellitus	0.000598	0.00939	CbGeAlD
Vinblastine—Vindesine—CYP3A4—type 2 diabetes mellitus	0.000592	0.371	CrCbGaD
Vinblastine—TUBB4A—retina—type 2 diabetes mellitus	0.00058	0.0091	CbGeAlD
Vinblastine—TUBA1A—cardiovascular system—type 2 diabetes mellitus	0.000574	0.00901	CbGeAlD
Vinblastine—JUN—cardiovascular system—type 2 diabetes mellitus	0.000568	0.00892	CbGeAlD
Vinblastine—TUBA1A—kidney—type 2 diabetes mellitus	0.000562	0.00881	CbGeAlD
Vinblastine—TUBB2B—retina—type 2 diabetes mellitus	0.00056	0.00879	CbGeAlD
Vinblastine—TUBA1A—pancreas—type 2 diabetes mellitus	0.000558	0.00875	CbGeAlD
Vinblastine—JUN—kidney—type 2 diabetes mellitus	0.000556	0.00873	CbGeAlD
Vinblastine—JUN—pancreas—type 2 diabetes mellitus	0.000553	0.00867	CbGeAlD
Vinblastine—TUBA1A—cortex of kidney—type 2 diabetes mellitus	0.000547	0.00858	CbGeAlD
Vinblastine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000544	0.00853	CbGeAlD
Vinblastine—JUN—cortex of kidney—type 2 diabetes mellitus	0.000542	0.0085	CbGeAlD
Vinblastine—TUBB4B—islet of Langerhans—type 2 diabetes mellitus	0.000529	0.0083	CbGeAlD
Vinblastine—TUBB2B—nephron tubule—type 2 diabetes mellitus	0.000528	0.00828	CbGeAlD
Vinblastine—TUBA1A—adipose tissue—type 2 diabetes mellitus	0.000506	0.00794	CbGeAlD
Vinblastine—JUN—adipose tissue—type 2 diabetes mellitus	0.000501	0.00787	CbGeAlD
Vinblastine—TUBB—nephron tubule—type 2 diabetes mellitus	0.000499	0.00784	CbGeAlD
Vinblastine—TUBB2A—nephron tubule—type 2 diabetes mellitus	0.000497	0.0078	CbGeAlD
Vinblastine—Vincristine—ABCC2—type 2 diabetes mellitus	0.000496	0.311	CrCbGaD
Vinblastine—TUBB4A—cardiovascular system—type 2 diabetes mellitus	0.000491	0.0077	CbGeAlD
Vinblastine—TUBB6—nephron tubule—type 2 diabetes mellitus	0.00049	0.00769	CbGeAlD
Vinblastine—TUBB4A—kidney—type 2 diabetes mellitus	0.00048	0.00753	CbGeAlD
Vinblastine—SLC22A2—kidney—type 2 diabetes mellitus	0.000478	0.0075	CbGeAlD
Vinblastine—TUBB4A—pancreas—type 2 diabetes mellitus	0.000477	0.00748	CbGeAlD
Vinblastine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000465	0.0073	CbGeAlD
Vinblastine—TUBB2B—pancreas—type 2 diabetes mellitus	0.000461	0.00723	CbGeAlD
Vinblastine—TUBB4B—retina—type 2 diabetes mellitus	0.000452	0.0071	CbGeAlD
Vinblastine—TUBB2B—cortex of kidney—type 2 diabetes mellitus	0.000452	0.00709	CbGeAlD
Vinblastine—TUBB6—cardiovascular system—type 2 diabetes mellitus	0.00044	0.00691	CbGeAlD
Vinblastine—TUBB—pancreas—type 2 diabetes mellitus	0.000436	0.00684	CbGeAlD
Vinblastine—TUBB2A—pancreas—type 2 diabetes mellitus	0.000434	0.00681	CbGeAlD
Vinblastine—TUBB6—kidney—type 2 diabetes mellitus	0.000431	0.00676	CbGeAlD
Vinblastine—TUBB6—pancreas—type 2 diabetes mellitus	0.000428	0.00671	CbGeAlD
Vinblastine—TUBB—cortex of kidney—type 2 diabetes mellitus	0.000427	0.00671	CbGeAlD
Vinblastine—TUBB4B—nephron tubule—type 2 diabetes mellitus	0.000426	0.00668	CbGeAlD
Vinblastine—TUBB2A—cortex of kidney—type 2 diabetes mellitus	0.000425	0.00667	CbGeAlD
Vinblastine—ABCC6—liver—type 2 diabetes mellitus	0.00042	0.00658	CbGeAlD
Vinblastine—TUBB6—cortex of kidney—type 2 diabetes mellitus	0.000419	0.00658	CbGeAlD
Vinblastine—TUBB2B—adipose tissue—type 2 diabetes mellitus	0.000418	0.00656	CbGeAlD
Vinblastine—TUBB—adipose tissue—type 2 diabetes mellitus	0.000396	0.00621	CbGeAlD
Vinblastine—TUBB2A—adipose tissue—type 2 diabetes mellitus	0.000394	0.00617	CbGeAlD
Vinblastine—TUBB6—adipose tissue—type 2 diabetes mellitus	0.000388	0.00609	CbGeAlD
Vinblastine—TUBB4B—cardiovascular system—type 2 diabetes mellitus	0.000383	0.006	CbGeAlD
Vinblastine—ABCB11—liver—type 2 diabetes mellitus	0.000376	0.0059	CbGeAlD
Vinblastine—TUBB4B—kidney—type 2 diabetes mellitus	0.000374	0.00587	CbGeAlD
Vinblastine—TUBB4B—pancreas—type 2 diabetes mellitus	0.000372	0.00583	CbGeAlD
Vinblastine—TUBB4B—cortex of kidney—type 2 diabetes mellitus	0.000365	0.00572	CbGeAlD
Vinblastine—TUBA1A—liver—type 2 diabetes mellitus	0.000355	0.00557	CbGeAlD
Vinblastine—JUN—liver—type 2 diabetes mellitus	0.000352	0.00552	CbGeAlD
Vinblastine—ABCC2—nephron tubule—type 2 diabetes mellitus	0.000345	0.00541	CbGeAlD
Vinblastine—TUBB4B—adipose tissue—type 2 diabetes mellitus	0.000337	0.00529	CbGeAlD
Vinblastine—TUBB4A—liver—type 2 diabetes mellitus	0.000303	0.00476	CbGeAlD
Vinblastine—ABCC2—kidney—type 2 diabetes mellitus	0.000303	0.00475	CbGeAlD
Vinblastine—ABCC2—cortex of kidney—type 2 diabetes mellitus	0.000295	0.00463	CbGeAlD
Vinblastine—Vinorelbine—CYP3A4—type 2 diabetes mellitus	0.000289	0.181	CrCbGaD
Vinblastine—TUBB—liver—type 2 diabetes mellitus	0.000277	0.00435	CbGeAlD
Vinblastine—TUBB2A—liver—type 2 diabetes mellitus	0.000276	0.00433	CbGeAlD
Vinblastine—TUBB6—liver—type 2 diabetes mellitus	0.000272	0.00427	CbGeAlD
Vinblastine—ABCC1—cortex of kidney—type 2 diabetes mellitus	0.00026	0.00408	CbGeAlD
Vinblastine—ABCC1—adipose tissue—type 2 diabetes mellitus	0.00024	0.00377	CbGeAlD
Vinblastine—Anorexia—Glimepiride—type 2 diabetes mellitus	0.000238	0.00188	CcSEcCtD
Vinblastine—Neuropathy peripheral—Metformin—type 2 diabetes mellitus	0.000238	0.00188	CcSEcCtD
Vinblastine—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000237	0.00188	CcSEcCtD
Vinblastine—Haemoglobin—Orlistat—type 2 diabetes mellitus	0.000237	0.00188	CcSEcCtD
Vinblastine—Pharyngitis—Valsartan—type 2 diabetes mellitus	0.000237	0.00188	CcSEcCtD
Vinblastine—TUBB4B—liver—type 2 diabetes mellitus	0.000237	0.00371	CbGeAlD
Vinblastine—Haemorrhage—Orlistat—type 2 diabetes mellitus	0.000236	0.00187	CcSEcCtD
Vinblastine—Angina pectoris—Losartan—type 2 diabetes mellitus	0.000235	0.00186	CcSEcCtD
Vinblastine—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.000234	0.00185	CcSEcCtD
Vinblastine—Anaemia—Glyburide—type 2 diabetes mellitus	0.000233	0.00184	CcSEcCtD
Vinblastine—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000233	0.00184	CcSEcCtD
Vinblastine—Nausea—Acarbose—type 2 diabetes mellitus	0.00023	0.00182	CcSEcCtD
Vinblastine—Pain—Glipizide—type 2 diabetes mellitus	0.000229	0.00181	CcSEcCtD
Vinblastine—Constipation—Glipizide—type 2 diabetes mellitus	0.000229	0.00181	CcSEcCtD
Vinblastine—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000226	0.00179	CcSEcCtD
Vinblastine—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.000226	0.00178	CcSEcCtD
Vinblastine—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000224	0.00177	CcSEcCtD
Vinblastine—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.000224	0.00177	CcSEcCtD
Vinblastine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000222	0.00175	CcSEcCtD
Vinblastine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000221	0.00175	CcSEcCtD
Vinblastine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00022	0.00174	CcSEcCtD
Vinblastine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000219	0.00173	CcSEcCtD
Vinblastine—Vincristine—CYP3A4—type 2 diabetes mellitus	0.000219	0.137	CrCbGaD
Vinblastine—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000219	0.00173	CcSEcCtD
Vinblastine—Convulsion—Glyburide—type 2 diabetes mellitus	0.000219	0.00173	CcSEcCtD
Vinblastine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000217	0.00172	CcSEcCtD
Vinblastine—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000217	0.00171	CcSEcCtD
Vinblastine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00171	CcSEcCtD
Vinblastine—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000215	0.0017	CcSEcCtD
Vinblastine—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000214	0.00169	CcSEcCtD
Vinblastine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00168	CcSEcCtD
Vinblastine—Pain—Sitagliptin—type 2 diabetes mellitus	0.000213	0.00168	CcSEcCtD
Vinblastine—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000211	0.00167	CcSEcCtD
Vinblastine—Alopecia—Valsartan—type 2 diabetes mellitus	0.000211	0.00167	CcSEcCtD
Vinblastine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000211	0.00167	CcSEcCtD
Vinblastine—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000211	0.00167	CcSEcCtD
Vinblastine—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00021	0.00166	CcSEcCtD
Vinblastine—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000209	0.00166	CcSEcCtD
Vinblastine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000209	0.00165	CcSEcCtD
Vinblastine—Alopecia—Orlistat—type 2 diabetes mellitus	0.000209	0.00165	CcSEcCtD
Vinblastine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000206	0.00163	CcSEcCtD
Vinblastine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000206	0.00163	CcSEcCtD
Vinblastine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000205	0.00162	CcSEcCtD
Vinblastine—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000204	0.00162	CcSEcCtD
Vinblastine—Malaise—Gliclazide—type 2 diabetes mellitus	0.000204	0.00162	CcSEcCtD
Vinblastine—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.000204	0.00161	CcSEcCtD
Vinblastine—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000204	0.00161	CcSEcCtD
Vinblastine—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000203	0.00161	CcSEcCtD
Vinblastine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000203	0.0016	CcSEcCtD
Vinblastine—Headache—Repaglinide—type 2 diabetes mellitus	0.000203	0.0016	CcSEcCtD
Vinblastine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000202	0.0016	CcSEcCtD
Vinblastine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000202	0.0016	CcSEcCtD
Vinblastine—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000202	0.0016	CcSEcCtD
Vinblastine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000202	0.00159	CcSEcCtD
Vinblastine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000201	0.00159	CcSEcCtD
Vinblastine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000197	0.00156	CcSEcCtD
Vinblastine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000197	0.00156	CcSEcCtD
Vinblastine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000197	0.00156	CcSEcCtD
Vinblastine—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000197	0.00156	CcSEcCtD
Vinblastine—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000196	0.00155	CcSEcCtD
Vinblastine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000196	0.00155	CcSEcCtD
Vinblastine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00155	CcSEcCtD
Vinblastine—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000196	0.00155	CcSEcCtD
Vinblastine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000193	0.00152	CcSEcCtD
Vinblastine—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000192	0.00152	CcSEcCtD
Vinblastine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000192	0.00152	CcSEcCtD
Vinblastine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000192	0.00152	CcSEcCtD
Vinblastine—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000192	0.00152	CcSEcCtD
Vinblastine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000191	0.00151	CcSEcCtD
Vinblastine—ABCC2—liver—type 2 diabetes mellitus	0.000191	0.003	CbGeAlD
Vinblastine—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000191	0.00151	CcSEcCtD
Vinblastine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000191	0.00151	CcSEcCtD
Vinblastine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000189	0.00149	CcSEcCtD
Vinblastine—Vertigo—Valsartan—type 2 diabetes mellitus	0.000187	0.00148	CcSEcCtD
Vinblastine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000186	0.00147	CcSEcCtD
Vinblastine—Malaise—Orlistat—type 2 diabetes mellitus	0.000185	0.00147	CcSEcCtD
Vinblastine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000185	0.00146	CcSEcCtD
Vinblastine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000185	0.00146	CcSEcCtD
Vinblastine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00146	CcSEcCtD
Vinblastine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000184	0.00145	CcSEcCtD
Vinblastine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000184	0.00145	CcSEcCtD
Vinblastine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000183	0.00145	CcSEcCtD
Vinblastine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000183	0.00145	CcSEcCtD
Vinblastine—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000182	0.00144	CcSEcCtD
Vinblastine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000181	0.00144	CcSEcCtD
Vinblastine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000181	0.00143	CcSEcCtD
Vinblastine—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000181	0.00143	CcSEcCtD
Vinblastine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000181	0.00143	CcSEcCtD
Vinblastine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000179	0.00142	CcSEcCtD
Vinblastine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000179	0.00142	CcSEcCtD
Vinblastine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000179	0.00141	CcSEcCtD
Vinblastine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000178	0.00141	CcSEcCtD
Vinblastine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00141	CcSEcCtD
Vinblastine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000177	0.0014	CcSEcCtD
Vinblastine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000176	0.00139	CcSEcCtD
Vinblastine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000175	0.00139	CcSEcCtD
Vinblastine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000173	0.00137	CcSEcCtD
Vinblastine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000172	0.00136	CcSEcCtD
Vinblastine—Malaise—Metformin—type 2 diabetes mellitus	0.000171	0.00135	CcSEcCtD
Vinblastine—Alopecia—Losartan—type 2 diabetes mellitus	0.000171	0.00135	CcSEcCtD
Vinblastine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000171	0.00135	CcSEcCtD
Vinblastine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00017	0.00135	CcSEcCtD
Vinblastine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00017	0.00135	CcSEcCtD
Vinblastine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00017	0.00134	CcSEcCtD
Vinblastine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000169	0.00134	CcSEcCtD
Vinblastine—ABCC1—liver—type 2 diabetes mellitus	0.000169	0.00264	CbGeAlD
Vinblastine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Vinblastine—Headache—Glipizide—type 2 diabetes mellitus	0.000168	0.00133	CcSEcCtD
Vinblastine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000166	0.00132	CcSEcCtD
Vinblastine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000166	0.00131	CcSEcCtD
Vinblastine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000166	0.00131	CcSEcCtD
Vinblastine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000165	0.00131	CcSEcCtD
Vinblastine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000165	0.00131	CcSEcCtD
Vinblastine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000165	0.0013	CcSEcCtD
Vinblastine—Hypertension—Metformin—type 2 diabetes mellitus	0.000164	0.00129	CcSEcCtD
Vinblastine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000163	0.00129	CcSEcCtD
Vinblastine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000162	0.00128	CcSEcCtD
Vinblastine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00128	CcSEcCtD
Vinblastine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000161	0.00128	CcSEcCtD
Vinblastine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000161	0.00127	CcSEcCtD
Vinblastine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000161	0.00127	CcSEcCtD
Vinblastine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.00016	0.00127	CcSEcCtD
Vinblastine—Discomfort—Metformin—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Vinblastine—Nausea—Glipizide—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Vinblastine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000159	0.00126	CcSEcCtD
Vinblastine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000158	0.00125	CcSEcCtD
Vinblastine—Pain—Gliclazide—type 2 diabetes mellitus	0.000158	0.00125	CcSEcCtD
Vinblastine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000158	0.00125	CcSEcCtD
Vinblastine—Headache—Glimepiride—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Vinblastine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000156	0.00124	CcSEcCtD
Vinblastine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000156	0.00123	CcSEcCtD
Vinblastine—Anaemia—Losartan—type 2 diabetes mellitus	0.000156	0.00123	CcSEcCtD
Vinblastine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000154	0.00122	CcSEcCtD
Vinblastine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00122	CcSEcCtD
Vinblastine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000154	0.00241	CbGeAlD
Vinblastine—CYP3A4—kidney—type 2 diabetes mellitus	0.000154	0.00241	CbGeAlD
Vinblastine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000152	0.00121	CcSEcCtD
Vinblastine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000152	0.0012	CcSEcCtD
Vinblastine—Malaise—Losartan—type 2 diabetes mellitus	0.000152	0.0012	CcSEcCtD
Vinblastine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000152	0.0012	CcSEcCtD
Vinblastine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Vinblastine—CYP2D6—kidney—type 2 diabetes mellitus	0.000151	0.00237	CbGeAlD
Vinblastine—Vertigo—Losartan—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Vinblastine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000151	0.0012	CcSEcCtD
Vinblastine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000151	0.00119	CcSEcCtD
Vinblastine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000151	0.00119	CcSEcCtD
Vinblastine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00015	0.00119	CcSEcCtD
Vinblastine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000149	0.00118	CcSEcCtD
Vinblastine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000148	0.00117	CcSEcCtD
Vinblastine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000148	0.00117	CcSEcCtD
Vinblastine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000148	0.00117	CcSEcCtD
Vinblastine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000148	0.00117	CcSEcCtD
Vinblastine—Anorexia—Metformin—type 2 diabetes mellitus	0.000147	0.00117	CcSEcCtD
Vinblastine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000146	0.00116	CcSEcCtD
Vinblastine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000146	0.00116	CcSEcCtD
Vinblastine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000146	0.00115	CcSEcCtD
Vinblastine—Constipation—Valsartan—type 2 diabetes mellitus	0.000145	0.00115	CcSEcCtD
Vinblastine—Pain—Orlistat—type 2 diabetes mellitus	0.000143	0.00114	CcSEcCtD
Vinblastine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00113	CcSEcCtD
Vinblastine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000143	0.00113	CcSEcCtD
Vinblastine—Discomfort—Losartan—type 2 diabetes mellitus	0.000142	0.00112	CcSEcCtD
Vinblastine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000141	0.00112	CcSEcCtD
Vinblastine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000141	0.00111	CcSEcCtD
Vinblastine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000139	0.0011	CcSEcCtD
Vinblastine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000139	0.0011	CcSEcCtD
Vinblastine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000139	0.0011	CcSEcCtD
Vinblastine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000138	0.00109	CcSEcCtD
Vinblastine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000137	0.00109	CcSEcCtD
Vinblastine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000136	0.00108	CcSEcCtD
Vinblastine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Vinblastine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Vinblastine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Vinblastine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Vinblastine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000134	0.00106	CcSEcCtD
Vinblastine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000133	0.00105	CcSEcCtD
Vinblastine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000133	0.00105	CcSEcCtD
Vinblastine—Constipation—Metformin—type 2 diabetes mellitus	0.000132	0.00105	CcSEcCtD
Vinblastine—ABCB1—retina—type 2 diabetes mellitus	0.000132	0.00206	CbGeAlD
Vinblastine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Vinblastine—Anorexia—Losartan—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Vinblastine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000131	0.00104	CcSEcCtD
Vinblastine—Malaise—Ramipril—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Vinblastine—Vertigo—Ramipril—type 2 diabetes mellitus	0.00013	0.00103	CcSEcCtD
Vinblastine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000129	0.00102	CcSEcCtD
Vinblastine—Headache—Glyburide—type 2 diabetes mellitus	0.000129	0.00102	CcSEcCtD
Vinblastine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000127	0.00101	CcSEcCtD
Vinblastine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000127	0.001	CcSEcCtD
Vinblastine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000126	0.001	CcSEcCtD
Vinblastine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000126	0.001	CcSEcCtD
Vinblastine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000125	0.00099	CcSEcCtD
Vinblastine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000125	0.000989	CcSEcCtD
Vinblastine—Pain—Irbesartan—type 2 diabetes mellitus	0.000125	0.000987	CcSEcCtD
Vinblastine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000125	0.000987	CcSEcCtD
Vinblastine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000124	0.00194	CbGeAlD
Vinblastine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000124	0.000978	CcSEcCtD
Vinblastine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000123	0.000975	CcSEcCtD
Vinblastine—Nausea—Glyburide—type 2 diabetes mellitus	0.000122	0.000967	CcSEcCtD
Vinblastine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000122	0.000967	CcSEcCtD
Vinblastine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000122	0.000967	CcSEcCtD
Vinblastine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000122	0.000964	CcSEcCtD
Vinblastine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000121	0.00096	CcSEcCtD
Vinblastine—Asthenia—Orlistat—type 2 diabetes mellitus	0.00012	0.000952	CcSEcCtD
Vinblastine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00012	0.000951	CcSEcCtD
Vinblastine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000119	0.000944	CcSEcCtD
Vinblastine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000119	0.000944	CcSEcCtD
Vinblastine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000118	0.00093	CcSEcCtD
Vinblastine—Pain—Losartan—type 2 diabetes mellitus	0.000117	0.000929	CcSEcCtD
Vinblastine—Constipation—Losartan—type 2 diabetes mellitus	0.000117	0.000929	CcSEcCtD
Vinblastine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000116	0.000919	CcSEcCtD
Vinblastine—Headache—Gliclazide—type 2 diabetes mellitus	0.000116	0.000916	CcSEcCtD
Vinblastine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000115	0.000913	CcSEcCtD
Vinblastine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000115	0.000912	CcSEcCtD
Vinblastine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000115	0.000908	CcSEcCtD
Vinblastine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000113	0.000895	CcSEcCtD
Vinblastine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000112	0.000888	CcSEcCtD
Vinblastine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000112	0.000888	CcSEcCtD
Vinblastine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000112	0.000888	CcSEcCtD
Vinblastine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000111	0.00175	CbGeAlD
Vinblastine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000111	0.000878	CcSEcCtD
Vinblastine—Asthenia—Metformin—type 2 diabetes mellitus	0.000111	0.000878	CcSEcCtD
Vinblastine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00011	0.000868	CcSEcCtD
Vinblastine—ABCB1—kidney—type 2 diabetes mellitus	0.000109	0.00171	CbGeAlD
Vinblastine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000109	0.000859	CcSEcCtD
Vinblastine—ABCB1—pancreas—type 2 diabetes mellitus	0.000108	0.0017	CbGeAlD
Vinblastine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000108	0.000854	CcSEcCtD
Vinblastine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000108	0.00085	CcSEcCtD
Vinblastine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000107	0.000844	CcSEcCtD
Vinblastine—Headache—Valsartan—type 2 diabetes mellitus	0.000106	0.000841	CcSEcCtD
Vinblastine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000106	0.00166	CbGeAlD
Vinblastine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000106	0.000837	CcSEcCtD
Vinblastine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000106	0.000836	CcSEcCtD
Vinblastine—Headache—Orlistat—type 2 diabetes mellitus	0.000105	0.000832	CcSEcCtD
Vinblastine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000828	CcSEcCtD
Vinblastine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000102	0.00081	CcSEcCtD
Vinblastine—Dizziness—Metformin—type 2 diabetes mellitus	0.000102	0.000809	CcSEcCtD
Vinblastine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000101	0.0008	CcSEcCtD
Vinblastine—Nausea—Valsartan—type 2 diabetes mellitus	0.000101	0.000798	CcSEcCtD
Vinblastine—Constipation—Ramipril—type 2 diabetes mellitus	0.000101	0.000797	CcSEcCtD
Vinblastine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	9.99e-05	0.00079	CcSEcCtD
Vinblastine—Nausea—Orlistat—type 2 diabetes mellitus	9.97e-05	0.000788	CcSEcCtD
Vinblastine—Asthenia—Losartan—type 2 diabetes mellitus	9.85e-05	0.000779	CcSEcCtD
Vinblastine—Vomiting—Metformin—type 2 diabetes mellitus	9.83e-05	0.000778	CcSEcCtD
Vinblastine—ABCB1—adipose tissue—type 2 diabetes mellitus	9.81e-05	0.00154	CbGeAlD
Vinblastine—CYP3A4—liver—type 2 diabetes mellitus	9.72e-05	0.00153	CbGeAlD
Vinblastine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000768	CcSEcCtD
Vinblastine—Headache—Metformin—type 2 diabetes mellitus	9.69e-05	0.000766	CcSEcCtD
Vinblastine—Dizziness—Irbesartan—type 2 diabetes mellitus	9.65e-05	0.000763	CcSEcCtD
Vinblastine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.63e-05	0.000762	CcSEcCtD
Vinblastine—CYP2D6—liver—type 2 diabetes mellitus	9.57e-05	0.0015	CbGeAlD
Vinblastine—Diarrhoea—Losartan—type 2 diabetes mellitus	9.4e-05	0.000743	CcSEcCtD
Vinblastine—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.31e-05	0.000736	CcSEcCtD
Vinblastine—Vomiting—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000734	CcSEcCtD
Vinblastine—Nausea—Metformin—type 2 diabetes mellitus	9.19e-05	0.000727	CcSEcCtD
Vinblastine—Headache—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000723	CcSEcCtD
Vinblastine—Dizziness—Losartan—type 2 diabetes mellitus	9.08e-05	0.000718	CcSEcCtD
Vinblastine—Vomiting—Losartan—type 2 diabetes mellitus	8.73e-05	0.000691	CcSEcCtD
Vinblastine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000686	CcSEcCtD
Vinblastine—Nausea—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000686	CcSEcCtD
Vinblastine—Headache—Losartan—type 2 diabetes mellitus	8.6e-05	0.000681	CcSEcCtD
Vinblastine—Asthenia—Ramipril—type 2 diabetes mellitus	8.45e-05	0.000668	CcSEcCtD
Vinblastine—Nausea—Losartan—type 2 diabetes mellitus	8.16e-05	0.000645	CcSEcCtD
Vinblastine—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.06e-05	0.000637	CcSEcCtD
Vinblastine—Dizziness—Ramipril—type 2 diabetes mellitus	7.79e-05	0.000616	CcSEcCtD
Vinblastine—Vomiting—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000592	CcSEcCtD
Vinblastine—Headache—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000584	CcSEcCtD
Vinblastine—Nausea—Ramipril—type 2 diabetes mellitus	7e-05	0.000553	CcSEcCtD
Vinblastine—ABCB1—liver—type 2 diabetes mellitus	6.88e-05	0.00108	CbGeAlD
Vinblastine—JUN—Signaling Pathways—C3—type 2 diabetes mellitus	3.78e-06	3.84e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	3.77e-06	3.83e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	3.73e-06	3.79e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.72e-06	3.78e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IRS1—type 2 diabetes mellitus	3.7e-06	3.76e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.68e-06	3.74e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	3.67e-06	3.74e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	3.66e-06	3.72e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	3.62e-06	3.69e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—ALB—type 2 diabetes mellitus	3.62e-06	3.68e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	3.61e-06	3.67e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.6e-06	3.66e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.59e-06	3.66e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AGT—type 2 diabetes mellitus	3.59e-06	3.65e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	3.56e-06	3.62e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	3.56e-06	3.62e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	3.55e-06	3.6e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—INS—type 2 diabetes mellitus	3.54e-06	3.6e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.53e-06	3.59e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.53e-06	3.59e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	3.52e-06	3.58e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APOE—type 2 diabetes mellitus	3.52e-06	3.58e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—LEP—type 2 diabetes mellitus	3.52e-06	3.58e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.49e-06	3.55e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—IL6—type 2 diabetes mellitus	3.49e-06	3.55e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	3.49e-06	3.54e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.48e-06	3.54e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	3.47e-06	3.53e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	3.47e-06	3.52e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—NOS3—type 2 diabetes mellitus	3.46e-06	3.52e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PIK3R1—type 2 diabetes mellitus	3.46e-06	3.52e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	3.43e-06	3.49e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	3.43e-06	3.49e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT2—type 2 diabetes mellitus	3.43e-06	3.48e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	3.42e-06	3.47e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.39e-06	3.44e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	3.38e-06	3.44e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.32e-06	3.37e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	3.32e-06	3.37e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	3.32e-06	3.37e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	3.31e-06	3.36e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	3.31e-06	3.36e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	3.31e-06	3.36e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	3.25e-06	3.31e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	3.25e-06	3.31e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.25e-06	3.3e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—NFKB1—type 2 diabetes mellitus	3.24e-06	3.29e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	3.23e-06	3.29e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	3.23e-06	3.29e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	3.23e-06	3.29e-05	CbGpPWpGaD
Vinblastine—JUN—Innate Immune System—AKT1—type 2 diabetes mellitus	3.22e-06	3.27e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.21e-06	3.26e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	3.19e-06	3.24e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	3.19e-06	3.24e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	3.17e-06	3.22e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	3.17e-06	3.22e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—PTGS2—type 2 diabetes mellitus	3.17e-06	3.22e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.15e-06	3.21e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.14e-06	3.19e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	3.12e-06	3.18e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	3.12e-06	3.18e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	3.12e-06	3.17e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—NOS3—type 2 diabetes mellitus	3.11e-06	3.16e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	3.11e-06	3.16e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	3.09e-06	3.14e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	3.06e-06	3.12e-05	CbGpPWpGaD
Vinblastine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.06e-06	3.11e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	3.05e-06	3.1e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	3.05e-06	3.1e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	3.04e-06	3.1e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	3.04e-06	3.1e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	3.04e-06	3.1e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	3.04e-06	3.09e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	3.03e-06	3.08e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	3.03e-06	3.08e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	3.03e-06	3.08e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—SRC—type 2 diabetes mellitus	3.02e-06	3.07e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—INS—type 2 diabetes mellitus	3.01e-06	3.06e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	3e-06	3.05e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	2.99e-06	3.04e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.97e-06	3.02e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—INS—type 2 diabetes mellitus	2.97e-06	3.02e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.96e-06	3.01e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	2.95e-06	3e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	2.95e-06	3e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	2.95e-06	3e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.94e-06	2.99e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.91e-06	2.96e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.9e-06	2.95e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	2.9e-06	2.95e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	2.9e-06	2.95e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	2.9e-06	2.95e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	2.84e-06	2.89e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	2.84e-06	2.89e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	2.82e-06	2.87e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	2.77e-06	2.82e-05	CbGpPWpGaD
Vinblastine—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.76e-06	2.81e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.76e-06	2.81e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.76e-06	2.8e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.73e-06	2.78e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.73e-06	2.78e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.73e-06	2.78e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	2.72e-06	2.77e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.68e-06	2.73e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.66e-06	2.7e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.65e-06	2.69e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—EGFR—type 2 diabetes mellitus	2.64e-06	2.69e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.64e-06	2.68e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.64e-06	2.68e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	2.63e-06	2.68e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.62e-06	2.66e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.62e-06	2.66e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.6e-06	2.65e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	2.6e-06	2.65e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2.6e-06	2.64e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	2.59e-06	2.64e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	2.58e-06	2.63e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.56e-06	2.6e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	2.51e-06	2.55e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.51e-06	2.55e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.51e-06	2.55e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.51e-06	2.55e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.51e-06	2.55e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.51e-06	2.55e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	2.5e-06	2.54e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—RELA—type 2 diabetes mellitus	2.48e-06	2.52e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.47e-06	2.51e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	2.47e-06	2.51e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.41e-06	2.45e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.4e-06	2.44e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	2.38e-06	2.42e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	2.37e-06	2.41e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.37e-06	2.41e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.37e-06	2.41e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—SRC—type 2 diabetes mellitus	2.3e-06	2.34e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.27e-06	2.3e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	2.27e-06	2.3e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.24e-06	2.28e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.23e-06	2.27e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.17e-06	2.2e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.17e-06	2.2e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.16e-06	2.19e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.13e-06	2.16e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.11e-06	2.15e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.09e-06	2.13e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.08e-06	2.12e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.07e-06	2.11e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.06e-06	2.1e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	2.05e-06	2.09e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.04e-06	2.08e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.04e-06	2.08e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.04e-06	2.07e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.04e-06	2.07e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.03e-06	2.07e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—IL6—type 2 diabetes mellitus	2.03e-06	2.07e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—EGFR—type 2 diabetes mellitus	2.01e-06	2.05e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.01e-06	2.04e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2e-06	2.04e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2e-06	2.04e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.99e-06	2.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.99e-06	2.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.99e-06	2.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.98e-06	2.01e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.97e-06	2e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—SRC—type 2 diabetes mellitus	1.95e-06	1.98e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.95e-06	1.98e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.94e-06	1.98e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.93e-06	1.96e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.92e-06	1.96e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.92e-06	1.95e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.9e-06	1.93e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.89e-06	1.92e-05	CbGpPWpGaD
Vinblastine—JUN—Immune System—AKT1—type 2 diabetes mellitus	1.87e-06	1.91e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.87e-06	1.9e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.86e-06	1.89e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.85e-06	1.88e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.82e-06	1.85e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.81e-06	1.84e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.79e-06	1.82e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.79e-06	1.82e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.79e-06	1.82e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.78e-06	1.8e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.77e-06	1.79e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.75e-06	1.78e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.74e-06	1.77e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.74e-06	1.77e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.74e-06	1.77e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.74e-06	1.77e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.71e-06	1.74e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.7e-06	1.73e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.69e-06	1.72e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.67e-06	1.7e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.66e-06	1.69e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.65e-06	1.68e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.64e-06	1.67e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.63e-06	1.66e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.63e-06	1.66e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.61e-06	1.64e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.61e-06	1.64e-05	CbGpPWpGaD
Vinblastine—ABCB11—Metabolism—AKT1—type 2 diabetes mellitus	1.59e-06	1.62e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.59e-06	1.62e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.56e-06	1.59e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.56e-06	1.58e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—IL6—type 2 diabetes mellitus	1.55e-06	1.57e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.55e-06	1.57e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.55e-06	1.57e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.54e-06	1.57e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.44e-06	1.46e-05	CbGpPWpGaD
Vinblastine—ABCC1—Disease—AKT1—type 2 diabetes mellitus	1.43e-06	1.45e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.41e-06	1.44e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.36e-06	1.38e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.33e-06	1.36e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.33e-06	1.36e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.33e-06	1.35e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.33e-06	1.35e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—IL6—type 2 diabetes mellitus	1.31e-06	1.34e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.31e-06	1.33e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.29e-06	1.32e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.27e-06	1.29e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.24e-06	1.26e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.22e-06	1.24e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.21e-06	1.24e-05	CbGpPWpGaD
Vinblastine—JUN—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.21e-06	1.23e-05	CbGpPWpGaD
Vinblastine—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	1.2e-06	1.22e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.19e-06	1.21e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.19e-06	1.21e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.17e-06	1.19e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.17e-06	1.19e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.15e-06	1.17e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.14e-06	1.16e-05	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-06	1.15e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.09e-06	1.11e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.07e-06	1.09e-05	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.07e-06	1.09e-05	CbGpPWpGaD
Vinblastine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	1.06e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.04e-06	1.06e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.02e-06	1.04e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.01e-06	1.02e-05	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	8.87e-07	9.02e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	8.7e-07	8.84e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	7.97e-07	8.11e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	7.63e-07	7.76e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	7.63e-07	7.76e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.98e-07	7.09e-06	CbGpPWpGaD
Vinblastine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	5.69e-07	5.79e-06	CbGpPWpGaD
Vinblastine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	5.36e-07	5.45e-06	CbGpPWpGaD
Vinblastine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.51e-07	3.57e-06	CbGpPWpGaD
